Tus kws kho mob
P8-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2911 - 2920 ntawm 3600
Tus kws kho mob
2020 January Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
P6-20 Sleep Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
P3-20 Radiology Oncology Imaging Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
P2-20 Radiation Oncology Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
P7-20 Musculoskeletal Management Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
P5-20 Cardiology & Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
P4-20 Lab Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
QP107-19 Medical Drug Update for Rituximab Biosimilars (Truxima, Ruxience) – Commercial Products
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 11, 2019
Tus kws kho mob
QP105-19 Understanding Vision Benefits within Eligibility & Benefits Inquiry Response
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 11, 2019